Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
ArriVent BioPharma, Inc.
13G/A
Amendment 1
AVBP · 04272N102
|
9.9% |
2/17/2026
Event 12/31/2025
|
|||
| Infinitum Asset Management, LLC | 9.9% | ||||
| Infinitum Partners GP, LLC | 9.9% | ||||
| Infinitum Cayman Master, Ltd. | 9.9% | ||||
|
ArriVent BioPharma, Inc.
13G
AVBP · 04272N102
|
9.9% |
8/13/2025
Event 5/1/2025
|
|||
| Infinitum Asset Management, LLC | 9.9% | ||||
| Infinitum Cayman Master, Ltd. (Fund) | 9.9% | ||||
| Infinitum Partners GP, LLC | 9.9% | ||||
|
ArriVent BioPharma, Inc.
13G
AVBP · 04272N102
|
6.1% |
5/15/2025
Event 5/1/2025
|
|||
| Infinitum Asset Management, LLC | 6.1% | ||||
| Infinitum Cayman Master, Ltd. | 6.1% | ||||
| Infinitum Partners GP, LLC | 6.1% | ||||